Asymmetric Synthesis of L-[β-11C]-3,4-Dihydroxyphenylalanine via the Chiral Ni(II) Complex of the Schiff Base Derived from (S)-o-N-(N'-Benzylprolyl)aminobenzophenone and Glycine (Ni-BPB-Gly)

被引:0
作者
O. F. Kuznetsova
I. K. Mosevich
M. V. Korsakov
O. S. Fedorova
R. N. Krasikova
机构
[1] Institute of Human Brain,Russian Academy of Sciences
关键词
Positron Emission Tomography; Schiff Base; Schiff; Dopa; Enantiomeric Excess;
D O I
10.1023/A:1022384427275
中图分类号
学科分类号
摘要
A procedure was proposed for asymmetric synthesis of L-[β-11C]-3,4-dihydroxyphenylalanine (L-[β-11C]DOPA), which is a radiotracer used for estimating the density of dopaminergic neurons by positron emission tomography (PET). The procedure involves the use of a new chiral inductor, the nickel complex of the Schiff base derived from (S)-o-N-(N'-benzylprolyl)aminobenzophenone and glycine (Ni-BPB-Gly). The reaction of the asymmetric inductor Ni-BPB-Gly with [α-11C]-3,4-dimethoxybenzyl bromide in the presence of potassium tert-butylate was performed in acetone at 80°C for 5 min. Decomposition of the resulting diastereomeric complex with 6 M HCl, followed by demethylation of hydroxy groups with concentrated HI, yielded L-DOPA. The radiochemical yield corrected for the 11C decay was 2-16% at the synthesis time of 60-66 min (with an RB-86 robotic system, Anatech). The enantiomeric excess (ee) of L-[β-11C]DOPA varied within 60-98%. The possibility of asymmetric synthesis of L-[β-11C]DOPA was demonstrated for the first time; however, the procedure requires further optimization.
引用
收藏
页码:582 / 587
页数:5
相关论文
共 53 条
  • [1] Raevskii K.S.(1996)undefined Usp. Fiziol. Nauk 27 3-29
  • [2] Sotnikova T.D.(1985)undefined J. Neurol. Sci. 69 223-230
  • [3] Gainetdinov R.R.(1990)undefined Biochem. Pharmacol. 39 1853-1860
  • [4] Nahmias C.(1997)undefined J. Label. Comp. Radiopharm. 40 202-204
  • [5] Garnett E.S.(1996)undefined J. Nucl. Med. 37 32-37
  • [6] Firnau G.(1990)undefined Acta Chem. Scand. 44 178-182
  • [7] Lang A.E.(1999)undefined Appl. Radiat. Isot. 50 715-721
  • [8] Melega W.(1976)undefined Eur. J. Nucl. Med. 1 11-14
  • [9] Luxen A.(1987)undefined Eur. J. Nucl. Med. 13 288-291
  • [10] Perlmutter M.M.(1995)undefined Acta Chem. Scand. 49 301-304